Business Directory, Press Releases, Jobs, Products, Services, Articles
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | News on Your Site

Press Releases

SMi Group

Press Release

Receive press releases from SMi Group: By Email RSS Feeds:

GSK and Lundbeck Present on Improving Drug-Drug Interaction at ADMET 2016

SMi reports: SMiís 11th annual conference and exhibition on ADMET will return to London on the 13th-14th June 2016.

London, United Kingdom, April 13, 2016 --( ADME and toxicology testing is one of the most important research activities related to new drug discovery. Ensuring a good ADMET study will accelerate approval and therefore commercialisation of drug products – and hence pharmacokinetics remain at the forefront of drug formulation and development.

Thanks to improved and innovative technologies, early stage ADME and toxicology screening of drug discovery and development process has become even more imperative.

As such, the 11th annual ADMET programme, sponsored by Corning and Sekisui XenoTech, will feature 3 keynotes from GSK, Lundbeck and InSilicoLynx Limited focusing on ‘Improving Drug-Drug Interaction’.

1. ‘Contribution of metabolites to DDI’ – Lena Gustavsson, Head of Drug-Drug Interactions, Lundbeck
2. ‘Estimating human plasma concentrations using in silico ADMET models´ - Mark Wenlok, Principal Scientist, InSilicoLynx Limited
3. ‘Role of drug transporters in drug delivery to CNS diseases’ – Kunal Taskar, Senior Investigator, DMPK, GSK

To download the full agenda with all sessions, speakers and their topics, please visit

What to expect?

ADMET 2016 will comprise of a series of practical case studies facilitated by leading industry experts who will provide you with best practices to:
• Optimise human ADMET studies to assess clinically-relevant drug bioavailability
• Use a population pharmacokinetic approach to assess DDI
• Evaluate and predict drug design interaction
• Review the structure based prediction of ADME properties
• Learn about In-Vivo drug-drug interaction
• Gain insight into PK/PD modelling to validate drug targets and toxicity

For those interested in attending visit the event website on

The final early bird will expire on the 29th of April, saving you £200. There is limited availability, so registration is encouraged to take place as soon as possible to ensure you secure your place.

For sponsorship enquiries, contact Alia Malick on +44 (0) 207 827 6168 or

For delegate enquiries, contact Matthew Apps on +44 (0) 207 827 6093 or

For media enquiries, contact Zoe Gale on +44 (0) 207 827 6132 or

11th annual ADMET conference and exhibition
13-14 June 2016
London, UK
Contact e-mail:
Contact tel: +44 (0) 207 827 6093

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at
Contact Information
SMi Group
Zoe Gale
+44 (0) 207 827 6093

Click here to view the list of recent Press Releases from SMi Group
Promote Your Business